DE69011122D1 - Rubella-e1 und c peptide. - Google Patents

Rubella-e1 und c peptide.

Info

Publication number
DE69011122D1
DE69011122D1 DE69011122T DE69011122T DE69011122D1 DE 69011122 D1 DE69011122 D1 DE 69011122D1 DE 69011122 T DE69011122 T DE 69011122T DE 69011122 T DE69011122 T DE 69011122T DE 69011122 D1 DE69011122 D1 DE 69011122D1
Authority
DE
Germany
Prior art keywords
rubella
rubella virus
useful
peptide
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69011122T
Other languages
English (en)
Other versions
DE69011122T2 (de
Inventor
Martial Lacroix
Maan Zrein
Gervais Dionne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adaltis Inc
Original Assignee
Adaltis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adaltis Inc filed Critical Adaltis Inc
Application granted granted Critical
Publication of DE69011122D1 publication Critical patent/DE69011122D1/de
Publication of DE69011122T2 publication Critical patent/DE69011122T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69011122T 1989-08-23 1990-08-17 Rubella-e1 und c peptide. Expired - Fee Related DE69011122T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/397,767 US5164481A (en) 1989-08-23 1989-08-23 Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus
PCT/CA1990/000263 WO1991002748A1 (en) 1989-08-23 1990-08-17 Rubella e1 peptides

Publications (2)

Publication Number Publication Date
DE69011122D1 true DE69011122D1 (de) 1994-09-01
DE69011122T2 DE69011122T2 (de) 1994-11-10

Family

ID=23572541

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69011122T Expired - Fee Related DE69011122T2 (de) 1989-08-23 1990-08-17 Rubella-e1 und c peptide.

Country Status (12)

Country Link
US (2) US5164481A (de)
EP (1) EP0491713B1 (de)
JP (1) JP3317967B2 (de)
AT (1) ATE109158T1 (de)
AU (1) AU646641B2 (de)
CA (1) CA2065022C (de)
DE (1) DE69011122T2 (de)
DK (1) DK0491713T3 (de)
ES (1) ES2057579T3 (de)
HU (1) HUT60508A (de)
OA (1) OA09653A (de)
WO (1) WO1991002748A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5427792A (en) * 1989-08-23 1995-06-27 Biochem Immunosystems, Inc. Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
GB9201139D0 (en) * 1992-01-20 1992-03-11 Connaught Lab Synthetic peptides for a rubella vaccine
US6008058A (en) * 1993-06-18 1999-12-28 University Of Louisville Cyclic peptide mixtures via side chain or backbone attachment and solid phase synthesis
US5510264A (en) * 1993-09-28 1996-04-23 Insight Biotech Inc. Antibodies which bind meningitis related homologous antigenic sequences
US6180758B1 (en) * 1994-10-06 2001-01-30 Connaught Laboratories Limited Synthetic peptides for rubella vaccine
DE69929468T2 (de) 1998-12-01 2006-09-14 Viral Antigens, Inc., Memphis VERBESSERTE SPEZIFITÄT IN DER DETEKTION DER ANTI-RUBELLA IgM ANTIKÖRPER
WO2008107187A1 (en) * 2007-03-06 2008-09-12 Ribovax Biotechnologies S.A. Antibodies specific for rubella virus
CN101402960B (zh) * 2008-08-13 2011-05-11 吴丽霞 一种重组风疹病毒e1蛋白及其应用
JP6095368B2 (ja) * 2009-10-27 2017-03-15 ユセベ ファルマ ソシエテ アノニム 機能改変するＮａｖ１．７抗体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003206A1 (en) * 1985-11-25 1987-06-04 Quash Gerard A Modified viral glycoproteins, diagnostic and therapeutic uses therefore
EP0299673A1 (de) * 1987-07-08 1989-01-18 London Biotechnology Limited E1-Glykoproteinantigene von Rubella

Also Published As

Publication number Publication date
CA2065022A1 (en) 1991-02-24
DE69011122T2 (de) 1994-11-10
DK0491713T3 (da) 1994-09-26
JPH04507409A (ja) 1992-12-24
US5164481A (en) 1992-11-17
WO1991002748A1 (en) 1991-03-07
AU646641B2 (en) 1994-03-03
ATE109158T1 (de) 1994-08-15
HUT60508A (en) 1992-09-28
JP3317967B2 (ja) 2002-08-26
EP0491713B1 (de) 1994-07-27
AU6151790A (en) 1991-04-03
US5298596A (en) 1994-03-29
EP0491713A1 (de) 1992-07-01
OA09653A (en) 1993-05-15
HU9200583D0 (en) 1992-05-28
CA2065022C (en) 2001-11-20
ES2057579T3 (es) 1994-10-16

Similar Documents

Publication Publication Date Title
DE3855947D1 (de) Peptide mit den immunologischen Eigenschaften von HIV-2
ATE98376T1 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
BR8701528A (pt) Proteina,sequencia de dna,vetor recombinante,organismo celular,processos para producao de uma proteina e para a preparacao de um organismo unicelular,processos para a deteccao da presenca de anticorpos e de virus de aids,processos para a preparacao de uma vacina e para a preparacao de anticorpos,formulacao de vacina,anticorpos,uso,vacina,kit de teste e metodo para a prevencao de aids
DE69111801D1 (de) Vakzin gegen hepatitis b.
ES2101388T3 (es) Antigenos sinteticos para la deteccion de anticuerpos para el virus de la hepatitis c.
WO1992017493A3 (en) Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
DE3682893D1 (de) Charakteristische polypeptide und antikoerper vom papillomavirus, diagnostische verfahren und dieselben verwendende impfungen.
ATE109158T1 (de) Rubella-e1 und c peptide.
DE69126577D1 (de) Antigenes Peptid zum Nachweis von Anti-Hepatitis-C-Virus-Antikörpern und dessen Verwendung
DE60125537D1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
FI101797B1 (fi) STLV-III-virukseen liittyvät polypeptidit, diagnostiset järjestelmät ja määritysmenetelmät
EP1878797A3 (de) Antigene Peptide zur Gruppierung des Hepatitis-C-Virus, Kit damit und Verfahren zur Gruppierung unter Verwendung dieses Kits
DE69928064D1 (de) Mimotopen der hypervariabele region des e2 glykoproteins von hcv und deren verwendungen
DK0704528T3 (da) Hæmorrhagisk sygdomsvirus hos kaniner (RHDV), rekombinante capsider og proteiner, diagnostiske kits og vacciner indeholdende dem
CA2141670A1 (en) Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus
FI923020A (fi) Inte a inte b-sekvenser.
DE69428984D1 (de) Stimulierung der immunantwort durch virales protein
ATE482974T1 (de) Multimere peptide, die auf dem hepatitis c virus hüllprotein basieren, für diagnostische verwendung und für impfzwecke
TW369600B (en) Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same
ATE540052T1 (de) Neue peptide, die epitope des humanen herpesvirus 8 darstellen
FI952778A0 (fi) Hepatiitti-C-viruksen (HCV) 3-ei-rakenne-peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi
EP0808846A3 (de) Peptide, die mit Antikörpern reagieren, die den Fortschritt der HIV-Erkrankung markieren
IT1270941B (it) Peptidi di hcv e loro usi.
FR2655855B1 (fr) Protection genetique d'animaux contre l'infection par le virus leucemogene bovin, et provirus et virus recombinant derive de ce virus.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ADALTIS INC., MONTREAL, QUEBEC, CH

8339 Ceased/non-payment of the annual fee